Spectral Ai completed its De Novo application submission to the FDA for the DeepView System in June 2025, marking a major regulatory milestone. Revenue for the quarter declined 32.0% year over year to ...
DALLAS, June 25, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more ...
Spectral AI Inc. (NASDAQ:MDAI) revealed Monday the performance results of its DeepView System in connection with the completion of its Burn Validation Study. Spectral AI, which focuses on medical ...
Spectral AI, a developer of the AI-driven DeepView® System for predicting burn healing, announced that national burn care leaders contributed over 511 in-person days to train and validate the system ...
Hosted on MSN
MDAI: DeepView FDA clearance fires up our valuation
Spectral AI, Inc. (NASDAQ: MDAI) announced De Novo clearance for its DeepView Burn diagnostic in a May 26 th press release. As a result, we increase our probability of success for DeepView burn from ...
Spectral AI, a Dallas-based company specializing in predictive AI for medical diagnostics, has announced the installation of three DeepView® System devices in Australia, following the Australian ...
(MENAFN- GlobeNewsWire - Nasdaq) Dr. Jeffrey Carter Awarded BBA Oral Presentation 1st Prize for his Paper on the Use of Multi-Spectral Imaging with Artificial Intelligence for Burn Wounds The ...
Dr. Jeffrey Carter Awarded BBA Oral Presentation 1st Prize for his Paper on the Use of Multi-Spectral Imaging with Artificial Intelligence for Burn Wounds DALLAS, June 25, 2026 (GLOBE NEWSWIRE) -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results